Galbot G1 Price 2026: Cost, Can You Buy It & What It Is

You cannot walk in and buy a Galbot G1, and the one time the public could, it was a stunt. The G1 is an enterprise robot sold in China by quote, not a product with a shelf price. The only retail moment came in February 2026, when two units went up on JD.com during the Spring Festival Gala broadcast for about 630,000 yuan (~$91,000) each and sold out in minutes. Real deployments run closer to 700,000 yuan a unit. JD later listed it in China at around 690,000 to 700,000 yuan too. What is not real is the Western commerce: the "$119,995 in stock" and "$55,000 prototype" listings are not confirmed Galbot channels.

What makes the G1 worth understanding is not the price, though. It is that Galbot's maker, Galaxy General, is the highest-valued embodied-AI company in China, and the G1 runs a genuine first: the country's first pharmacy licensed to operate with a robot, where the G1 is the certified robot pharmacy assistant. This page covers what it costs, who makes it, what it can actually do, and where the marketing outruns the hardware.

Can you buy a Galbot G1, and what does it cost?

No, not as a consumer, and there is no established channel outside China, though one G1 was imported to Japan for business testing in 2026. Galbot sells the G1 to businesses through a quoted deployment, integrated per site. There is no public list price and no "buy" button on its own site. The real price signals are the flash-sale price, a standing JD listing, and enterprise pricing; treat the Western commerce listings as unofficial.

Quick facts and key specifications

Unlike most Chinese makers, Galbot publishes a full spec sheet in its developer manual, so the figures below are official rather than the reseller guesses that disagree with each other elsewhere online. Full verified specs also live in the Galbot G1 record in the RoboZaps robot database.

The one thing nearly every aggregator gets wrong: the G1 is not bipedal. It rides a 360-degree wheeled base on a single lifting column that raises and lowers the whole torso, so it can reach a top shelf or a low bin without legs. Anyone describing it as a walking humanoid has not read Galbot's own spec sheet.

Which prices are real, and which are not

There is no global list price, but there are real Chinese figures and then listings that are not confirmed Galbot channels:

• ~630,000 yuan (~$91,000) was the flash-sale price for two units on JD.com during the Spring Festival Gala. Promotional, and only two units.
• ~690,000 to 700,000 yuan is the standing figure JD showed for the G1 in China after the Gala, and roughly 700,000 yuan is what enterprise pharmacy deployments reportedly cost. A "$97,000" tag online is just the dollar conversion of that, not an invented number.
• $119,995 "in stock" and $175,000 AUD "ships within a week" appear on Western storefronts with "add to cart" buttons. Galbot sells no inventory through these Western storefronts, so treat them as unconfirmed, not channels you can actually buy through.
• A $55,000 "prototype" on a spec aggregator is likewise unverified and traces to no Galbot source.

One more trap worth naming: the Unitree G1 is a completely different robot from a different company: a roughly $16,000 bipedal humanoid that shares only the "G1" name. Prices like "85,000 yuan" or "$13,500" belong to the Unitree machine, not this one. If a page quotes a low-five-figure price for a "G1," it is almost certainly describing Unitree's robot by mistake.

Who makes it: Galaxy General

Galbot is the product brand of Galaxy General (Beijing Galbot Co.), founded in May 2023 and now, by valuation, the leading embodied-AI startup in China. It was co-founded by Wang He, a Peking University professor with a Stanford robotics PhD who still runs a joint lab at PKU, alongside Yao Tengzhou, who leads hardware and commercialisation. By the company's own December 2025 announcement it had raised over $800 million at a roughly $3 billion valuation, and it followed that with a reported 2.5-billion-yuan round in March 2026. Its backer list reads like a who's-who of Chinese strategics: battery giant CATL led a $153 million round in 2025, and Meituan, IDG Capital, Qiming and Sequoia China are all in. The pitch is full-stack embodied AI: build the data, the foundation models and the robot in-house, and use unmanned retail and pharmacy as the way in.

The design and hardware

The G1's shape follows its job. Manipulation, not walking, is the point, so Galaxy General skipped legs and put a capable dual-arm torso on a stable wheeled base. The left arm ends in a suction cup for flat and bagged items; the right uses an adaptive parallel gripper for grasping. The lifting column gives it a working envelope from floor level to roughly 2.4 metres, which is what lets a single robot stock a shelf and pick from a bin.

On compute, there are two tiers. The standard G1 runs on NVIDIA's previous-generation Jetson Orin class. The G1 Premium upgrades to NVIDIA's Jetson AGX Thor, which Galbot says made it the first company to put Thor in a humanoid, claiming roughly 7.5 times the AI compute and 3.5 times the energy efficiency of the Orin generation. Galbot's developer manual lists a fuller sensor suite than the two arms suggest: a binocular camera in the head, four torso RGB cameras, depth cameras and six-axis force sensors at both wrists, a 3D LiDAR and eight ultrasonic sensors on the chassis, and inertial units for balance. It is built to navigate and manipulate a real store, not just pose for a demo.

The AI, and how autonomous it really is

The interesting part is the software. Galaxy General trains its robots largely on synthetic data generated in simulation, then fine-tunes on real data. Its grasping foundation model, GraspVLA, was pre-trained on a billion-frame synthetic grasping dataset and published as a paper in 2025; a retail-specific model, GroceryVLA, handles picking varied and fragile products off cluttered shelves without being reprogrammed for each item. The company's strongest genuine autonomy proof is a competition: at the 2025 World Humanoid Robot Games, the G1 won the pharmaceutical-sorting event outright and fully autonomously, while, as founder Wang He pointed out, most rivals were teleoperated.

That said, the live-deployment reality is narrower than the highlight reels. Reporters who visited Galaxy General's own stores found the robot slow and brittle: at a FamilyMart it handled fewer than ten of the store's roughly one thousand products and failed to grasp chip bags about four times in ten, and the store still ran four human staff. At the pharmacy, one reporter noted the robot "had not yet learned the locations of medicines." Humans still handle payment everywhere, and pharmacists still review every prescription. The autonomy is real, but it is a curated set of tasks done reliably, not a general worker.

The deployment record

Galaxy General's track record is genuinely ahead of most humanoid makers on one axis, regulated retail, and thinner than the headlines on the rest.

Two caveats keep this honest. First, the impressive industrial names are orders and collaborations, not confirmed running deployments, and CATL is also an investor, which blurs "customer." Second, on scale: one on-the-ground report put Galaxy General's actual output at fewer than 150 robots a year, so the "thousands of units" you see quoted are order backlog, not an installed base. The pharmacy authorisation, though, is the real milestone: a regulator licensed a store to run a robot pharmacy assistant, which no competitor has matched. Around seven Beijing robot-pharmacy deployments were reported by mid-2025, growing to about ten by March 2026, before and around that permit.

G1, G1 Premium, and the S1

Three names get confused, so here is the map. The G1 is the standard wheeled manipulator on Jetson Orin. The G1 Premium is the same platform with Jetson Thor compute for buyers who want maximum on-board autonomy. There is no "G2." The next distinct product is the S1, a heavy-load industrial robot powered by a CATL battery and reported on CATL's own production lines in 2026. Galbot's own launch release claimed a 50 kg-class dual-arm payload, though its current developer manual specifies 30 kg combined. It is a different machine for a different job, not a G1 successor.

How it compares

The G1 is not really competing with the walking humanoids people picture, like Tesla's Optimus, Figure's robots, or Unitree's bipeds. Those chase general mobility; the G1 is a purpose-built manipulator that trades legs for a stable base and spends its intelligence on grasping. Against other wheeled manipulators and enterprise service robots it is unusually far along commercially, precisely because Galaxy General narrowed the problem to shelves and counters. If you are comparing it to a Unitree G1, stop: that is a different, cheaper, bipedal research robot that happens to share a name.

Who the Galbot G1 is for

This is an enterprise robot for Chinese retail, pharmacy, logistics and, increasingly, factory operators who want a robot that can pick and place across a real catalogue without bespoke tooling for each item. It is not for consumers, has no established buyer channel outside China (beyond a single unit imported to Japan for testing), and is not for anyone who needs a robot that walks or works out of the box today. If you are a Western buyer who found a "G1 in stock" page, it is not a confirmed Galbot channel; the only real path is a quoted deployment through Galbot.

What to watch

Three things will tell you whether Galaxy General's lead is real. Watch whether it actually reaches mass production in 2026 rather than the sub-150-units-a-year it reportedly ships now; whether the November-2025 shift to a joint-stock structure turns into an IPO; and whether any of the marquee industrial partnerships convert into disclosed, running deployments rather than announced orders. The pharmacy authorisation gives it a genuine moat in regulated retail. The open question is whether the hardware can scale as fast as the valuation implies.

The bottom line

The Galbot G1 is the most commercially advanced wheeled manipulator to come out of China's embodied-AI boom, backed by its best-funded company and validated by a first-of-its-kind licensed robot pharmacy. But you cannot buy one unless you are an enterprise buyer, almost always in China, it has no global list price, and the Western "in stock" listings are not confirmed Galbot channels. Judge it on what it verifiably does, which is pick and pack a curated catalogue, slowly but in a licensed store, and on whether Galaxy General can turn a $3 billion valuation and fewer than 150 robots a year into the scale it is promising.